Figure 1.
Overview of the concept of DC/DCleu-based immunotherapy depicting the steps of generating DCleu through DC/DCleu-generating protocols in the dendritic cell culture (DCC) and stimulating T cell enriched immunoreactive cells with generated DCleu in the mixed lymphocyte culture (MLC), overall leading to anti-leukaemic cytotoxicity of T cell enriched immunoreactive cells.